Patient-led Active Tuberculosis Case-finding in the Democratic Republic of the Congo
Overview
Authors
Affiliations
Objective: To investigate the effect of using volunteer screeners in active tuberculosis case-finding in South Kivu, the Democratic Republic of the Congo, especially among groups at high risk of tuberculosis infection.
Methods: To identify and screen high-risk groups in remote communities, we trained volunteer screeners, mainly those who had themselves received treatment for tuberculosis or had a family history of the disease. A non-profit organization was created and screeners received training on the disease and its transmission at 3-day workshops. Screeners recorded the number of people screened, reporting a prolonged cough and who attended a clinic for testing, as well as test results. Data were evaluated every quarter during the 3-year period of the intervention (2014-2016).
Findings: Acceptability of the intervention was high. Volunteers screened 650 434 individuals in their communities, 73 418 of whom reported a prolonged cough; 50 368 subsequently attended a clinic for tuberculosis testing. Tuberculosis was diagnosed in 1 in 151 people screened, costing 0.29 United States dollars (US$) per person screened and US$ 44 per person diagnosed. Although members of high-risk groups with poorer access to health care represented only 5.1% (33 002/650 434) of those screened, they contributed 19.7% (845/4300) of tuberculosis diagnoses (1 diagnosis per 39 screened). The intervention resulted in an additional 4300 sputum-smear-positive pulmonary tuberculosis diagnoses, 42% (4 300/10 247) of the provincial total for that period.
Conclusion: Patient-led active tuberculosis case-finding represents a valuable complement to traditional case-finding, and should be used to assist health systems in the elimination of tuberculosis.
Kerkhoff A, Foloko M, Kundu-Ngandu E, Nyirenda H, Jabbie Z, Syulikwa M Front Public Health. 2025; 12:1408213.
PMID: 39872096 PMC: 11769986. DOI: 10.3389/fpubh.2024.1408213.
Taylor M, Medley N, Van Wyk S, Oliver S Cochrane Database Syst Rev. 2024; 3:CD014756.
PMID: 38511668 PMC: 10955804. DOI: 10.1002/14651858.CD014756.pub2.
Intervention Effect of New Tuberculosis Control Model on Tuberculosis Incidence in Xinjiang.
Zhang Y, Wang X, Liu N, Wang S, Wang X, Cao M Infect Drug Resist. 2023; 16:7485-7496.
PMID: 38089956 PMC: 10711297. DOI: 10.2147/IDR.S441899.
Fenta M, Ogundijo O, Warsame A, Belay A BMC Infect Dis. 2023; 23(1):515.
PMID: 37550614 PMC: 10405492. DOI: 10.1186/s12879-023-08502-7.
Kerkhoff A, Mwamba C, Pry J, Kagujje M, Nyangu S, Mateyo K PLOS Glob Public Health. 2023; 3(6):e0001372.
PMID: 37327200 PMC: 10275452. DOI: 10.1371/journal.pgph.0001372.